Bropirimine
Cat.No:IB1740 Solarbio
CAS:56741-95-8
Molecular Formula:C10H8BrN3O
Molecular Weight:266.09
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Immunology & Inflammation >
BropirimineCAS:56741-95-8
Molecular Formula:C10H8BrN3O
Molecular Weight:266.09
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 56741-95-8 |
Name | Bropirimine |
Molecular Formula | C10H8BrN3O |
Molecular Weight | 266.09 |
Solubility | Soluble in DMSO(Need ultrasonic) |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00813905 |
SMILES | C1=CC=C(C=C1)C2=C(C(=O)NC(=N2)N)Br |
InChIKey | CIUUIPMOFZIWIZ-UHFFFAOYSA-N |
InChI | InChI=1S/C10H8BrN3O/c11-7-8(6-4-2-1-3-5-6)13-10(12)14-9(7)15/h1-5H,(H3,12,13,14,15) |
PubChem CID | 135413497 |
Target Point | Toll-like Receptor (TLR7) |
Passage | Immunology & Inflammation |
Background | Bropirimine is an agonist of toll-like receptor 7 (TLR7). Bropirimine mediates IFN through TLR7- β Its production inhibits the differentiation of osteoclast precursor cells into osteoclasts. |
Unit | Bottle |
Specification | 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.